The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
A study on the prediction model of carotid unstable plaque protein and its early
intervention. Protein antibody chip was used to detect the remaining biological samples, and
patients with carotid artery unstable plaque with stroke risk were selected for
interventional clinical trials.
The selected patients were randomly divided into 3 groups, which were treated with Zhu's
Wenban Formula (TCM compound granules), Qushi Formula (TCM compound granules) and placebo for
6 months, respectively. The size and number of carotid artery unstable plaques before and
after 6 months were observed, and the occurrence of adverse reactions during the intervention
period was observed.
Phase:
Phase 1
Details
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine